Earnings Feed
Sign Up
Home/Filings/4/0001209191-17-061053
4//SEC Filing

CESARIO FRANK 4

Accession 0001209191-17-061053

CIK 0000883107other
View on SEC.govCompany Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 9:04 AM ET

Size

25.6 KB

Accession

0001209191-17-061053

Insider Transaction Report

Form 4
Period: 2017-11-14
NANOPHASE TECHNOLOGIES CorpNANX
CESARIO FRANK
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2017-11-14$0.61/sh−7,400$4,514→ 83,783 total
  • Exercise/Conversion

    Common Stock (right to buy)

    2017-11-15$0.30/sh−13,667$4,100→ 0 total
    Exercise: $0.30From: 2013-08-07Exp: 2022-08-07→ Common Stock (13,667 underlying)
  • Exercise/Conversion

    Common Stock (right to buy)

    2017-11-15$0.41/sh−13,000$5,395→ 0 total
    Exercise: $0.41From: 2014-02-14Exp: 2023-02-14→ Common Stock (13,000 underlying)
  • Exercise/Conversion

    Common Stock

    2017-11-15$0.30/sh+6,167$1,850→ 89,950 total
  • Sale

    Common Stock

    2017-11-15$0.59/sh−13,000$7,670→ 83,783 total
  • Exercise/Conversion

    Common Stock

    2017-11-14$0.30/sh+7,400$2,220→ 91,183 total
  • Sale

    Common Stock

    2017-11-15$0.61/sh−6,167$3,762→ 83,783 total
  • Exercise/Conversion

    Common Stock

    2017-11-15$0.42/sh+13,000$5,460→ 96,783 total
Holdings

  • Common Stock (right to buy)

    Exercise: $0.52From: 2015-02-13Exp: 2024-02-13→ Common Stock (40,000 underlying)
    40,000

  • Common Stock

    Exercise: $0.42From: 2017-02-23Exp: 2026-02-23→ Common Stock (31,500 underlying)
    31,500

  • Common Stock (right to buy)

    Exercise: $1.07From: 2010-06-24Exp: 2019-06-24→ Common Stock (20,000 underlying)
    20,000

  • Common Stock (right to buy)

    Exercise: $1.26From: 2012-05-02Exp: 2021-05-02→ Common Stock (31,000 underlying)
    31,000

  • Common Stock (right to buy)

    Exercise: $1.70From: 2011-05-03Exp: 2020-05-03→ Common Stock (20,000 underlying)
    20,000

  • Common Stock

    Exercise: $0.68From: 2018-02-21Exp: 2027-02-21→ Common Stock (36,000 underlying)
    36,000

  • Common Stock (right to buy)

    Exercise: $0.44From: 2016-02-18Exp: 2025-02-18→ Common Stock (36,000 underlying)
    36,000
Footnotes (1)
  • [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Documents

1 file

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

→
Entity typeother

Related Parties

1
  • filerCIK 0001267497

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:04 AM ET
Size
25.6 KB
View on SEC.gov